Evidence map›Paper›PMID 34149923›Full record

ArticleJournal of Cancer2021

Haoyang Hu, Sheng Yin, Ruyue Ma, Rujun Chen, Shuqing Li, Yaping Chen, He Fei, Lina Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Haoyang HuDepartment of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, People's Republic of China.
Sheng YinDepartment of Obstetrics and Gynecology, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, People's Republic of China.
Ruyue MaDepartment of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, People's Republic of China.
Rujun ChenDepartment of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, People's Republic of China.
Shuqing LiObstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, People's Republic of China.
Yaping ChenDepartment of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, People's Republic of China.
He FeiDepartment of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, People's Republic of China.
Lina YangDepartment of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Shanghai, People's Republic of China.
Fudan University · CNObstetrics and Gynecology Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CREBBP, in short CBP, has been reported to be involved in tumorigenesis in various cancers, but its role in ovarian cancer remains largely unexplored. In our study, survival analysis of CBP in patients with ovarian cancer was conducted using the Kaplan-Meier Plotter database, then we utilized specific shRNA targeting

Indexed as

apoptosischemo-sensitivityCREBBPovarian cancerUPR

Identifiers

PMID34149923
PMCPMC8210551
OpenAlexW3172655866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.